Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-30 @ 4:38 AM
Study NCT ID:
NCT01887067
Status:
TERMINATED
Last Update Posted:
2022-11-18
First Post:
2013-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus
Sponsor:
Pamela Youde Nethersole Eastern Hospital
Organization:
Study Overview
Official Title:
Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus
Status:
TERMINATED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Slow recruitment and change in clinical evidence
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HTN2DM
Brief Summary:
To demonstrate the efficacy of renal denervation therapy in treating resistant hypertension and its effect on glucose metabolism in patients with type 2 diabetes mellitus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: